Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC)

  • M. G. Fury
  • , E. J. Sherman
  • , S. S. Rao
  • , S. Wolden
  • , S. Smith-Marrone
  • , B. Mueller
  • , K. K. Ng
  • , P. R. Dutta
  • , D. Y. Gelblum
  • , J. L. Lee
  • , R. Shen
  • , S. Kurz
  • , N. Katabi
  • , S. Haque
  • , N. Y. Lee
  • , D. G. Pfister

Research output: Contribution to journal › Article › peer-review

23 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC)'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science